Kyokumido Hospital, Japan
New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve!
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma
Gastrointestinal Diseases Are On The Rise, How To Fight The "Battle For Your Stomach"?
New TCR-T Therapy Afami-cel For Advanced Sarcoma With Promising And Long-Lasting Results!